About Bio-Optronics
Bio-Optronics is a Healthcare company based in Rochester (United States) founded in 1985, and was acquired by Advarra in March 2021. Clinical trial management systems are provided for healthcare workflow optimization. Bio-Optronics has raised $30 million across 1 funding round from investors including Advarra and Mainsail Partners. Bio-Optronics offers products and services including Clinical Conductor, eReg, and eSource + EDC. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Suvoda, HumanFirst and Circuit Clinical; 3 of its 3 listed competitors have raised funding.
Company details
Bio-Optronics was founded in 1985 in Rochester, United States, within the healthcare IT sector. Software products and custom solutions are developed, deployed, and operated to support clinical trial management, including recruitment, scheduling, data capture, and collaboration. Clinical Conductor serves as an enterprise CTMS for sites, sponsors, CROs, and academic centers, while bioPoint addresses patient safety through registration, identification, and medication administration processes.
- Headquarters Rochester, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bio-optronics.com
- Social LinkedIn X Facebook
- Acquired by Advarra (Mar 2021)
Products & Services of Bio-Optronics
Bio-Optronics offers a comprehensive portfolio of products and services, including Clinical Conductor, eReg, and eSource + EDC.
Manages clinical trials for efficiency and financial tracking
Ensures compliance with regulatory and eConsent workflows
Captures and manages clinical data with remote workflows
Funding Insights of Bio-Optronics
Bio-Optronics has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series B round of $30 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 1
- Last Round Series B — $30M
- First Round $30M
(Jan 2018)
- Investors Count 1
All 1 funding rounds of Bio-Optronics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $30M | Series B | – | Mainsail Partners | – |
2 investors in total: 2 institutional.
Investors in Bio-Optronics
Bio-Optronics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Advarra and Mainsail Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity fund focused on multiple sectors | mainsailpartners.com | San Francisco, United States | ||
Global research compliance services including IRB and consulting are provided. | 2017 | advarra.com | Columbia, United States |
Investor details for Bio-Optronics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bio-Optronics
1 people are tracked at Bio-Optronics (1 in team).
| Name | Role | Group |
|---|---|---|
William Sharp | Sales & Marketing | Team |
Complete people profiles for Bio-Optronics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bio-Optronics
3 dated milestones of Bio-Optronics across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Bio-Optronics is founded.
- Funding First funding round of $30.0M.
- Exit Acquired by Advarra.
Competitors of Bio-Optronics
Bio-Optronics has 3 listed competitors in our database, 3 of them funded. They include Suvoda, HumanFirst and Circuit Clinical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| suvoda.com | 2012 | Conshohocken, United States | $40M | 302 | Clinical trial management solutions are provided through Suvoda's IRT system. | |
| gohumanfirst.com | 2017 | San Francisco, United States | $14.9M | 344 | HumanFirst is integrated into ICON, focusing on digital health solutions. | |
| circuitclinical.com | 2014 | Buffalo, United States | $47.67M | Research site network platform focuses on patient identification, enrollment, recruitment & retention |
Detailed competitors of Bio-Optronics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio-Optronics
Websites that share an audience with Bio-Optronics (bio-optronics.com).
Websites whose visitors overlap most with Bio-Optronics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
associatedneurologists.com | associatedneurologists.com | 100% | – | ||
clinicalconductor.com | clinicalconductor.com | 91% | #371,831 | – | |
themedical.com | themedical.com | 64% | – | ||
| mypatientscheduler.com | 62% | View details | |||
| endurid.com | 60% | 1.3K | #12,908,209 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Bio-Optronics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio-Optronics
Complete news archive for Bio-Optronics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio-Optronics
Bio-Optronics was founded in 1985 and raised its 1st funding round 33 years after it was founded.
Bio-Optronics is headquartered in Rochester, United States.
Bio-Optronics is a funded company, having raised a total of $30M across 1 funding round to date. The company's 1st funding round was a Series B of $30M, raised on Jan 2018.
Bio-Optronics was founded in 1985 in Rochester, United States, within the healthcare IT sector. Software products and custom solutions are developed, deployed, and operated to support clinical trial management, including recruitment, scheduling, data capture, and collaboration. Clinical Conductor serves as an enterprise CTMS for sites, sponsors, CROs, and academic centers, while bioPoint addresses patient safety through registration, identification, and medication administration processes.
Bio-Optronics's top competitors include Suvoda, HumanFirst and Circuit Clinical.
Bio-Optronics offers Clinical Conductor, eReg, and eSource + EDC.
Bio-Optronics has 2 investors. Key investors include Advarra, and Mainsail Partners.
Yes. Bio-Optronics was acquired by Advarra in March 2021.